According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

The shares of Cipla dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to ...

Aurobindo Pharma’s wholly owned subsidiary Auro Pharma acquires Khandelwal Laboratories’ non-oncology prescription ...

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has received a Notice of Compliance from Health Canada for its biosimilar Dyrupeg. The regulatory nod confirms the drug meets safety and quality ...

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Auro Pharma Limited, has approved the ...

Aurobindo Pharma Limited has revised timeline for completing its proposed captive solar power arrangement and equity ...

Aurobindo Pharma's subsidiary receives Health Canada NOC for Dyrupeg, confirming its pegylated filgrastim biosimilar's safety ...

Aurobindo Ltd. and Aurobindo USA were hit with a patent infringement lawsuit on Oct. 9 in Delaware District Court. The action, brought by McCarter & English and Arnold & Porter Kaye Scholer on behalf ...

Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received Health Canada’s compliance notice for its biosimilar ...

HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal ...

Aurobindo Pharma and its U.S. subsidiary were hit with a patent infringement lawsuit on July 1 in Delaware District Court. The action, brought by Haug Partners and Faegre Drinker Biddle & Reath on ...